Construction Substantially Complete on Krystal Biotech's $80 Million ASTRA Gene Therapy Plant, an Industrial Info Market Brief
Construction Substantially Complete on Krystal Biotech's $80 Million ASTRA Gene Therapy Plant, an Industrial Info Market Brief
Attachment: krystal, Map
Early last year, construction began on Krystal Biotech's second gene therapy manufacturing plant in Findley Township, Pennsylvania. The company built the commercial-scale plant to avoid being caught in the current shortfall in production capacity for cell and gene therapies.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Plastic, Rubber Product-Makers Expand Amid Rising Demand
- Big-Ticket Items Lead North Carolina to $18.7 Billion in Projects Under Con...
- ISM: U.S. Manufacturing Activity Contracts Again But Shows Improvement
- Florida Sees $7.2 Billion in Industrial Projects Under Construction
- U.S. Baked Goods Projects Worth Billions
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
